SCL SCIENCE INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,970 KRW | +1.93% |
|
+11.15% | +1.13% |
Business Summary
Sales per Business
| KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Service
45.6
%
| - | - | 603 | 45.6 % | - |
Hemostatic Agent
33.5
%
| 345 | 93.2 % | 444 | 33.5 % | +28.70% |
Catheter
19.9
%
| 25 | 6.8 % | 263 | 19.9 % | +946.40% |
Non-implantable Vascular Access Devices (Grade 2)
1.0
%
| - | - | 13 | 1.0 % | - |
Sales per region
| KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
South Korea
89.9
%
| 209 | 56.5 % | 1,189 | 89.9 % | +468.83% |
United States
7.9
%
| 99 | 26.7 % | 104 | 7.9 % | +5.31% |
Hong Kong
1.7
%
| 14 | 3.8 % | 22 | 1.7 % | +58.26% |
Greece
0.4
%
| 10 | 2.6 % | 6 | 0.4 % | -41.41% |
Japan
0.1
%
| 3 | 0.9 % | 2 | 0.1 % | -50.70% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Moon-Soo Lee
FOU | Founder | 50 | 10-04-18 |
In-Geun Mun
DFI | Director of Finance/CFO | 57 | - |
Hong-Gi Kim
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Taek-Soo Kang
AUD | Comptroller/Controller/Auditor | 64 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
In-Geun Mun
DFI | Director of Finance/CFO | 57 | - |
Moon-Soo Lee
FOU | Founder | 50 | 10-04-18 |
Hong-Gi Kim
CTO | Chief Tech/Sci/R&D Officer | 48 | - |
Jong-Man Kim
BRD | Director/Board Member | 52 | 20-03-26 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 7,236,830 | 5,149,318 ( 71.15 %) | 0 | 71.15 % |
| Stock B | 0 | 42,149 | 0 | 0 |
Company contact information
InnoTherapy, Inc.
Unit 1206-1210, ACE Hitech City 2 25 Seonyu-ro 13-gil
07282, Seoul
+
http://www.innotherapy.com
Sector
Sales per Business
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| +1.13% | 46.27M | |
| -4.06% | 86.13B | |
| +1.97% | 39.82B | |
| +56.59% | 25.23B | |
| -14.82% | 15.36B | |
| -8.82% | 11.95B | |
| -16.29% | 11.6B | |
| -41.58% | 11.51B | |
| +6.14% | 8.71B | |
| -7.02% | 8.12B |
- Stock Market
- Equities
- A246960 Stock
- Company SCL Science Inc.
